Related Experiment Video
Updated: Sep 29, 2025

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
Signaling Pathways Involved in 5-FU Drug Resistance in Cancer
Fahima Danesh Pouya1, Yousef Rasmi1,2, Mohadeseh Nemati1
1Department of Biochemistry, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran.
Abstract:
Anti-metabolite drugs prevent the synthesis of essential cell growth compounds. 5-fluorouracil is used as an anti-metabolic drug in various cancers in the first stage of treatment. Unfortunately, in some cancers, 5-fluorouracil has low effectiveness because of its drug resistance. Studies have shown that drug resistance to 5-fluorouracil is due to the activation of specific signaling pathways and increased expressions of enzymes involved in drug metabolites. However, when 5-fluorouracil is used in combination with other drugs, the sensitivity of cancer cells to 5-fluorouracil increases, and the effect of drug resistance is reversed. This study discusses how the function of 5-fluorouracil in JAK/STAT, Wnt, Notch, NF-κB, and hedgehogs in some cancers.
Insights
5-fluorouracil resistance in cancer can be overcome by combination therapies. This study explores how 5-fluorouracil interacts with key signaling pathways like JAK/STAT to reverse drug resistance.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- 5-fluorouracil (5-FU) is a cornerstone anti-metabolite chemotherapy agent.
- Drug resistance significantly limits 5-FU's efficacy in treating various cancers.
- Mechanisms of resistance involve altered signaling pathways and enzyme expression.
Purpose of the Study:
- To investigate the role of 5-FU in specific cancer signaling pathways.
- To understand how combination therapies can overcome 5-FU resistance.
- To elucidate the molecular mechanisms underlying 5-FU's effectiveness and resistance.
Main Methods:
- Review of existing literature on 5-FU resistance mechanisms.
- Analysis of signaling pathways including JAK/STAT, Wnt, Notch, NF-κB, and hedgehog.
- Discussion of combination therapy strategies.
Main Results:
- Activation of specific signaling pathways contributes to 5-FU resistance.
- Combination treatments can restore cancer cell sensitivity to 5-FU.
- Understanding pathway interactions is key to overcoming resistance.
Conclusions:
- Targeting or modulating pathways like JAK/STAT, Wnt, Notch, NF-κB, and hedgehog can enhance 5-FU therapy.
- Combination strategies offer a promising approach to reverse 5-FU drug resistance.
- Further research into these interactions may lead to improved cancer treatment protocols.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Treatment Resistant Cancers
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

